EUVIMEDEUVIMED entdecken
Crossref

Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization

Xiang Sun, Xun Zhang, Yawei Zhao, Wei Zheng, Ruijie Li, Jieqiong Zhao

Experimental Brain Research · 2027-12 · 245 (1)

DOI: 10.1007/s00221-026-07431-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Brain Research, online erschienen am 19.11.2026. Verfasst von Xiang Sun und 5 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sun, X., Zhang, X., Zhao, Y., Zheng, W., Li, R., & Zhao, J. (2027). Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization. Experimental Brain Research, 245(1). https://doi.org/10.1007/s00221-026-07431-6

Vancouver

Sun X, Zhang X, Zhao Y, Zheng W, Li R, Zhao J. Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization. Experimental Brain Research. 2027;245(1). doi:10.1007/s00221-026-07431-6

BibTeX
@article{Sun2027,
  author = {Sun, Xiang and Zhang, Xun and Zhao, Yawei and Zheng, Wei and Li, Ruijie and Zhao, Jieqiong},
  title = {Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization},
  journal = {Experimental Brain Research},
  year = {2027},
  volume = {245},
  number = {1},
  doi = {10.1007/s00221-026-07431-6}
}
Kostenlos starten →